Ablacath™ Mapping Catheter

Ablacath™ Mapping Catheter is an FDA 510(k)-cleared medical device (K223666) manufactured by Ablacon, Inc.. This device is classified under the Cardiovascular specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on March 16, 2023. Regulation: 8.